deltatrials
Active Not Recruiting INTERVENTIONAL NCT06045962

Optimal Stent Duration After Ureteroscopy

Effect of Three vs Seven Day Ureteral Stent Removal After Ureteroscopy on Stent Related Symptoms

Sponsor: Mayo Clinic

Conditions Ureteral Stent
Interventions Ureteral stent
Updated 10 times since 2023 Last updated: Apr 16, 2026 Started: Nov 1, 2023 Primary completion: Sep 1, 2026 Completion: Sep 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06045962, this observational or N/A phase trial focuses on Ureteral Stent and remains ongoing. Sponsored by Mayo Clinic, it has been updated 10 times since 2023, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Study Description(click to expand)

The rationale for this study is to determine if there is a difference in symptoms or complications among patients undergoing uncomplicated ureteroscopy for stone removal with shorter indwelling stent duration. Currently there are only a few small studies exploring the optimal duration of stent placement after stent placement and no multicenter randomized control trials. The investigation aim is to determine if earlier ureteral stent removal will reduce urinary symptoms after stent removal and improve quality of life without increasing risk of negative side effects. Using questionnaires for stent related symptoms the researchers will assess stent indwelling time effect on patient reported side effects.

The rationale for this study is to determine if there is a difference in symptoms or complications among patients undergoing uncomplicated ureteroscopy for stone removal with shorter indwelling stent duration. Currently there are only a few small studies exploring the optimal duration of stent placement after stent placement and no multicenter randomized control trials. The investigation aim is to determine if earlier ureteral stent removal will reduce urinary symptoms after stent removal and improve quality of life without increasing risk of negative side effects. Using questionnaires for stent related symptoms the researchers will assess stent indwelling time effect on patient reported side effects.

Status Flow

~Oct 2023 – ~Nov 2023 · 31 days · monthly snapshot~Nov 2023 – ~Dec 2023 · 30 days · monthly snapshot~Dec 2023 – ~Jan 2024 · 31 days · monthly snapshot~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshotEnrolling By Invitation~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Sep 2025 · 10 months · monthly snapshotEnrolling By Invitation~Sep 2025 – ~Nov 2025 · 2 months · monthly snapshot~Nov 2025 – ~Apr 2026 · 6 months · monthly snapshotEnrolling By InvitationApr 21, 2026 – present · 3 months · daily API

Change History

10 versions recorded
  1. Apr 21, 2026 — Present [daily]

    Active Not Recruiting

    Status: Enrolling By InvitationActive Not Recruiting · Phase: NANone

  2. Nov 2025 — Apr 2026 [monthly]

    Enrolling By Invitation NA

  3. Sep 2025 — Nov 2025 [monthly]

    Enrolling By Invitation NA

  4. Nov 2024 — Sep 2025 [monthly]

    Enrolling By Invitation NA

  5. Sep 2024 — Nov 2024 [monthly]

    Enrolling By Invitation NA

Show 5 earlier versions
  1. Jul 2024 — Sep 2024 [monthly]

    Enrolling By Invitation NA

  2. Jan 2024 — Jul 2024 [monthly]

    Enrolling By Invitation NA

    Status: Not Yet RecruitingEnrolling By Invitation

  3. Dec 2023 — Jan 2024 [monthly]

    Not Yet Recruiting NA

  4. Nov 2023 — Dec 2023 [monthly]

    Not Yet Recruiting NA

  5. Oct 2023 — Nov 2023 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

The purpose of this study is to determine how soon ureteral stents can be safely removed following surgery.

Contact Information

Sponsor contact:
  • Mayo Clinic
Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .